Clinical Trials Logo

Clinical Trial Summary

This is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS). The objective of this study is to evaluate the implantation of the HM3 utilizing techniques other than full median sternotomy (e.g. thoracotomy) and impact on post-implant length of stay.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

  • Advanced Refractory Left Ventricular Heart Failure
  • Heart Failure

NCT number NCT04548128
Study type Observational
Source Abbott Medical Devices
Status Completed
Start date November 17, 2020
Completion date December 20, 2022

See also
  Status Clinical Trial Phase
Completed NCT02224755 - MOMENTUM 3 IDE Clinical Study Protocol N/A
Completed NCT03022461 - HeartMate 3 CE Mark Study Long Term Follow-up
Completed NCT02170363 - HeartMate 3™ CE Mark Clinical Investigation Plan N/A
Completed NCT03982979 - MOMENTUM 3 Pivotal Cohort Extended Follow-up PAS
Completed NCT02892955 - MOMENTUM 3 Continued Access Protocol N/A